Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Less than 24M shares in the O/S and about 11M in the float, makes for an easy mover either way with volume.
CLDN
SS
Yes, strange the way this stock moves.
The sp certainly moves fast. It dipped to 1.415 and flew back up to the 1.50's in a blink of the eye.
CLDN
Still holding and back to green.
Good luck to all longs..we know what we have here !
WOW VERY IMPRESSIVE.......http://ih.advfn.com/p.php?pid=nmona&article=69719789
Welcome aboard !
Yes,had me worried and was about to dump my remaining 4300 shares.
Then I thought to myself....why did I buy this stock and decided not to sell ..this is a keeper .
These type of stocks (if everything falls in place ) can trade in the hundreds and that is no joke !
CLDN just now hit 1.43... new hod.
I agree. Nice!
CLDN
Things are looking good over here today Marilyn
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)
http://ih.advfn.com/p.php?pid=nmona&article=69719789&symbol=CLDN
Eiger prospectus out this morning, interesting read, know what you own.
Also an 8K for Eiger:
The sp went down nine days in a row. Let's hope it goes up nine days in a row.
Up a dime today, not bad after the past week.
CLDN
SS
I don't understand the dips either but it's nice to be able to take advantage of them.
Thank you. I don't understand the dips the past few days, but I'm not complaining.
Green always looks good. Several dollars will look better!
Nice to CLDN up if only by a few cents.
SS
Immediately prior to the effective time of the merger, each share of Eiger preferred stock will be converted into shares of Eiger common stock at a ratio determined in accordance with the Eiger
certificate of incorporation then in effect and each outstanding warrant to purchase Eiger equity securities will be automatically exercised. At the effective time of the merger, each share of Eiger
common stock will be converted into the right to receive approximately 1.32 shares of Celladon common stock, subject to adjustment to account for the effect of a reverse stock split of Celladon
common stock, at a ratio of one new share for every fifteen shares outstanding, to be implemented prior to the consummation of the merger as discussed in this proxy
statement/prospectus/information statement. Celladon will assume outstanding and unexercised options to purchase Eiger common stock, and they will be converted into options to purchase
Celladon common stock. Celladon stockholders will continue to own and hold their existing shares of Celladon common stock. Immediately after the merger, Eiger stockholders, warrantholders
and optionholders will own approximately 78% of the fully-diluted common stock of Celladon, with Celladon optionholders and stockholders, whose shares of Celladon stock will remain
outstanding after the merger, holding approximately 22% of the fully-diluted common stock of Celladon. The exchange ratio is determined pursuant to a formula described in more detail in the
Merger Agreement and in the attached proxy statement/prospectus/information statement, and the 1.32 figure and percentage ownership figures are estimates.
Congrats on the cheap shs today. I added a few more and am maxed out now.
I just jumped back in. CLDN looks like it will turn back up.
It's disappointing to see CLDN go down today but we've seen how fast the sp can move up. On 11/20/14 it ran down to $1 and closed @1.255. The following day it hit 1.74 and was higher than that in extended trading. It can be a little stressful to watch.
S-4 filing this AM
I feel the same as you.
I was hoping for some sort of PR regarding Cleveland on 12/09/2105. Nothing. I wonder who is minding the store since he has left. And Why would the board members be minding the store if they definitely know they are going to be kick out of the company. They are soon to be the outgoing executive board members, as The CEO Cleveland were the first out going kick out executive board member. Why would any of them stick around unless, they're paid to stay or maybe waiting on a servant package.
It this is the case I don't see any news release taking place for the changing of the guards. Than on that day I think we get a pr. I think the Leader and his excutive board member already know that we are going to vote for the merger. What else do we have that we can us to vote no that will keep Celladon in Charge instead of Elger. We are only going to get 22% of what in reality. Maybe as shareholders we should increase our percentage in the new company. Celladon is already establish. Elger is looking for a shell to take over with their handful of triggets.
I've been looking into stock-drop lawsuits and it looks like CLDN is a victim of one here. Many of the articles rightfully claim that the lawsuit is partly to blame for many drops that happen to companies and many people would like these types of suits brought to a end as they seem to help the law firms that file them.
http://www.bloombergview.com/articles/2014-06-23/there-will-always-be-stock-drop-lawsuits
If you are a investor who bought when the price was over $20 a share,this lawsuit my look like a welcome sight.
I still see this going back to multiple $'s as soon as the merger is complete. This week should provide great buying opportunities, if I can clear some funds I'm gonna buy a few and hold for a while.
It looks like the perfect storm is brewing here. These prices are looking like a great bargain here.
The chart is almost set to pop on this one.
CLDN - Let's not forget the Merger...
Eiger BioPharma eyes the shell of Celladon to back its way onto Wall Street
November 19, 2015 | By Damian Garde
Privately held Eiger BioPharmaceuticals has signed a deal to merge with failed gene therapy biotech Celladon ($CLDN), looking to make its way onto Wall Street and press forward with a handful of treatments for rare disease.
Under the deal, Eiger's shareholders would take control of Celladon, a once-promising company that plunged into penny-stock territory after the failure of its cardiac treatment. Eiger's backers have put an initial $6 million into the company to support its plan, and they've promised another $33.5 million if and when the merger closes, which the company expects to happen in the first half of next year.
If Celladon shareholders sign off on the deal, the combined company will do business under Eiger's name and move forward with more than $60 million in cash, the company said.
http://www.fiercebiotech.com/story/eiger-biopharma-eyes-shell-celladon-back-its-way-wall-street/2015-11-19
When I left for my trip on Tuesday, CLDN was trading @1.42/1.43. Knowing that it recently hit $1 and then rebounded, I placed a buy order for more shs @1.25 but didn't think it would likely get filled. Last night when I returned I was both surprised and happy that it was filled because I remember the sp previously moved up from $1 to 1.74 the very next day. It can do it again if we simply ignore the law firms and wait for an update from the company.
CLDN!
I agree 100% with your assessment, well stated.
CLDN
SS
I've been out of town for several days and returned late last night and read your post.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=119065339
It appears that the law firms hope to drum up a little business so they can profit from the merger. Ambulance chasers always show up. I emailed Johnson & Weaver and immediately was sent a contract to sign that would allow them to represent me. I declined because I feel that we don't need them involved.
http://www.wallstreetscope.com/investigation-for-investors-in-shares-of-celladon-corp-nasdaqcldn-over-acquisition-announced/25531436/
http://ih.advfn.com/p.php?pid=nmona&article=69392741
Right now they're hurting the investors by causing the sp to move down. That's likely what they hope to accomplish in order to cause us to think we need their services.
Any thoughts here?
9 days in a row red...
I was looking at the chart and I agree with you. The bottom should be at or near $1.00 if it falls into the low .90's
It could keep going awhile until news turns it around.
What comes first, the bounce or the news? Either way I see a $1 coming.
Many in the sector have gotten their butts kicked. This and IMNP are getting killed. Both have a lot of potential. The markets are getting killed as well. Pending rate hike could bring this lower for a while. Tax write-off selling will happen as well, especially for those who bought at 1.50+.
No material reason that I can find. Think the low volume and down markets have affected CLDN. In MAJOR over sold territory.
SS
Down and down here. Why??
Reversal in progress, way over sold now.
CLDN
SS
unbeal...volume is low if that's any consolation...lol
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1047
|
Created
|
12/03/14
|
Type
|
Free
|
Moderators |
About the Proposed Merger
Existing Eiger stockholders as well as investors in the contemporaneous financing will receive newly issued shares of Celladon common stock in connection with the proposed merger. Celladon is expected to issue approximately 85.0 million new shares of its common stock to Eiger stockholders and participants in the financing. On a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.
The transaction has been unanimously approved by the boards of directors of both companies, and a majority of Eiger stockholders have agreed to vote in favor of the transaction. The proposed merger is expected to close in the first half of 2016, subject to the approval of the stockholders of each company as well as regulatory approval and other customary conditions. The merger agreement contains further details with respect to the proposed merger.
Celladon’s exclusive financial advisor in the transaction is Wedbush PacGrow Healthcare. Jefferies LLC is acting as lead financial advisor to Eiger and Piper Jaffray is acting as financial advisor. Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Celladon and Cooley LLP served as legal counsel to Eiger.
Chart
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |